Status:
UNKNOWN
Generic Immunosuppressive Drugs After Lung Transplantation
Lead Sponsor:
Hannover Medical School
Conditions:
Immunosuppressive After Lung Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Extent of use of generics immunosuppressive drugs in clinical practice after lung transplantation
Detailed Description
Solid organ transplant recipients are treated with immunosuppressive drugs to prevent rejection of their grafts. The most frequently important maintenance immunosuppressive drugs in Europe are calcine...
Eligibility Criteria
Inclusion
- patients after lung transplantation (single, double or combined)
- informed consent
- patient with an immunosuppressive therapy with tacrolimus or ciclosporin
Exclusion
- immunosuppressive therapy without calcineurin inhibitors
- need for isolation (Colonization with multi. or pan resistant organisms e.g. methicillin-resistant staph. aureus\[MRSA), B. cenocepacia)
- limited German language skills or other reasons which might impair patient communication or computer handling
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2014
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01889017
Start Date
July 1 2013
End Date
September 1 2014
Last Update
July 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hannover Medical School
Hanover, Lower Saxony, Germany, 30625